Cargando…
Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease()
BACKGROUND AND AIMS: Crohn's disease (CD) is a chronic inflammatory bowel disease associated with psychological stress that is regulated primarily by the hypothalamus-pituitary-adrenal (HPA) axis. Here, we determined whether the psychological characteristics of CD patients associate with their...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728050/ https://www.ncbi.nlm.nih.gov/pubmed/35024638 http://dx.doi.org/10.1016/j.bbih.2021.100407 |
_version_ | 1784626647485382656 |
---|---|
author | Nemirovsky, Anna Ilan, Karny Lerner, Livnat Cohen-Lavi, Liel Schwartz, Doron Goren, Ganit Sergienko, Ruslan Greenberg, Dan Slonim-Nevo, Vered Sarid, Orly Friger, Michael Regev, Shirley Odes, Shmuel Hertz, Tomer Monsonego, Alon |
author_facet | Nemirovsky, Anna Ilan, Karny Lerner, Livnat Cohen-Lavi, Liel Schwartz, Doron Goren, Ganit Sergienko, Ruslan Greenberg, Dan Slonim-Nevo, Vered Sarid, Orly Friger, Michael Regev, Shirley Odes, Shmuel Hertz, Tomer Monsonego, Alon |
author_sort | Nemirovsky, Anna |
collection | PubMed |
description | BACKGROUND AND AIMS: Crohn's disease (CD) is a chronic inflammatory bowel disease associated with psychological stress that is regulated primarily by the hypothalamus-pituitary-adrenal (HPA) axis. Here, we determined whether the psychological characteristics of CD patients associate with their inflammatory state, and whether a 3-month trial of cognitive-behavioral and mindfulness-based stress reduction (COBMINDEX) impacts their inflammatory process. METHODS: Circulating inflammatory markers and a wide range of psychological parameters related to stress and well-being were measured in CD patients before and after COBMINDEX. Inflammatory markers in CD patients were also compared to age- and sex-matched healthy controls (HCs). RESULTS: CD patients exhibited increased peripheral low-grade inflammation compared with HCs, demonstrated by interconnected inflammatory modules represented by IL-6, TNFα, IL-17, MCP-1 and IL-18. Notably, higher IL-18 levels correlated with higher score of stress and a lower score of wellbeing in CD patients. COBMINDEX was accompanied by changes in inflammatory markers that coincided with changes in cortisol: changes in serum levels of cortisol correlated positively with those of IL-10 and IFNα and negatively with those of MCP-1. Furthermore, inflammatory markers of CD patients at baseline predicted COBMINDEX efficacy, as higher levels of distinct cytokines and cortisol at baseline, correlated negatively with changes in disease activity (by Harvey-Bradshaw Index) and psychological distress (global severity index measure) following COBMINDEX. CONCLUSION: CD patients have a characteristic immunological profile that correlates with psychological stress, and disease severity. We suggest that COBMINDEX induces stress resilience in CD patients, which impacts their well-being, and their disease-associated inflammatory process. |
format | Online Article Text |
id | pubmed-8728050 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-87280502022-01-11 Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease() Nemirovsky, Anna Ilan, Karny Lerner, Livnat Cohen-Lavi, Liel Schwartz, Doron Goren, Ganit Sergienko, Ruslan Greenberg, Dan Slonim-Nevo, Vered Sarid, Orly Friger, Michael Regev, Shirley Odes, Shmuel Hertz, Tomer Monsonego, Alon Brain Behav Immun Health Full Length Article BACKGROUND AND AIMS: Crohn's disease (CD) is a chronic inflammatory bowel disease associated with psychological stress that is regulated primarily by the hypothalamus-pituitary-adrenal (HPA) axis. Here, we determined whether the psychological characteristics of CD patients associate with their inflammatory state, and whether a 3-month trial of cognitive-behavioral and mindfulness-based stress reduction (COBMINDEX) impacts their inflammatory process. METHODS: Circulating inflammatory markers and a wide range of psychological parameters related to stress and well-being were measured in CD patients before and after COBMINDEX. Inflammatory markers in CD patients were also compared to age- and sex-matched healthy controls (HCs). RESULTS: CD patients exhibited increased peripheral low-grade inflammation compared with HCs, demonstrated by interconnected inflammatory modules represented by IL-6, TNFα, IL-17, MCP-1 and IL-18. Notably, higher IL-18 levels correlated with higher score of stress and a lower score of wellbeing in CD patients. COBMINDEX was accompanied by changes in inflammatory markers that coincided with changes in cortisol: changes in serum levels of cortisol correlated positively with those of IL-10 and IFNα and negatively with those of MCP-1. Furthermore, inflammatory markers of CD patients at baseline predicted COBMINDEX efficacy, as higher levels of distinct cytokines and cortisol at baseline, correlated negatively with changes in disease activity (by Harvey-Bradshaw Index) and psychological distress (global severity index measure) following COBMINDEX. CONCLUSION: CD patients have a characteristic immunological profile that correlates with psychological stress, and disease severity. We suggest that COBMINDEX induces stress resilience in CD patients, which impacts their well-being, and their disease-associated inflammatory process. Elsevier 2021-12-23 /pmc/articles/PMC8728050/ /pubmed/35024638 http://dx.doi.org/10.1016/j.bbih.2021.100407 Text en © 2021 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Full Length Article Nemirovsky, Anna Ilan, Karny Lerner, Livnat Cohen-Lavi, Liel Schwartz, Doron Goren, Ganit Sergienko, Ruslan Greenberg, Dan Slonim-Nevo, Vered Sarid, Orly Friger, Michael Regev, Shirley Odes, Shmuel Hertz, Tomer Monsonego, Alon Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease() |
title | Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease() |
title_full | Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease() |
title_fullStr | Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease() |
title_full_unstemmed | Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease() |
title_short | Brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: Observations from a randomized controlled trial in patients with Crohn's disease() |
title_sort | brain-immune axis regulation is responsive to cognitive behavioral therapy and mindfulness intervention: observations from a randomized controlled trial in patients with crohn's disease() |
topic | Full Length Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728050/ https://www.ncbi.nlm.nih.gov/pubmed/35024638 http://dx.doi.org/10.1016/j.bbih.2021.100407 |
work_keys_str_mv | AT nemirovskyanna brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease AT ilankarny brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease AT lernerlivnat brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease AT cohenlaviliel brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease AT schwartzdoron brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease AT gorenganit brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease AT sergienkoruslan brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease AT greenbergdan brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease AT slonimnevovered brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease AT saridorly brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease AT frigermichael brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease AT regevshirley brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease AT odesshmuel brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease AT hertztomer brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease AT monsonegoalon brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease AT brainimmuneaxisregulationisresponsivetocognitivebehavioraltherapyandmindfulnessinterventionobservationsfromarandomizedcontrolledtrialinpatientswithcrohnsdisease |